Valdés Delgado Teresa
9PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|Oct 18, 2024
Carriage of the HLA-DQA1⋆05 haplotype is associated with a higher risk of infratherapeutic drug concentration and higher immunogenicity in patients undergoing treatment with anti-TNF for inflammatory bowel disease.Pilar Navajas Hernández, Samer Mouhtar El Halabi, Ana Caridad González Parra
|Sep 11, 2024
High serum levels of ustekinumab are associated with better clinical outcomes during maintenance treatment for inflammatory bowel disease.Jaime González-Antuña, Teresa Valdés-Delgado, Belén Maldonado-Pérez
|Jul 31, 2024
Long-Term Outcomes of Intravenous Ustekinumab Maintenance Treatment in Patients With Loss of Response to Subcutaneous Dosing.Federico Argüelles-Arias, F Javier Rodriguez González, Jaime González Antuña
|Sep 01, 2023
Intravenous ustekinumab maintenance treatment in patients with loss of response to subcutaneous dosing.Federico Argüelles-Arias, Teresa Valdés Delgado, Belén Maldonado Pérez
|Feb 13, 2023
Effectiveness and safety of ustekinumab in bio-naïve Crohn's disease patients: a multicentre observational retrospective study.Valdés Delgado Teresa, Olmedo Martín Rául, Iborra Marisa
|Feb 22, 2022
Cap-Polyposis: A Cause of Treatment Failure in Ulcerative Colitis.Teresa Valdés Delgado, Daniel Barranco Castro, Federico Argüelles Arias
Pageof 2
Frequent Collaborators
1 joint publications
Carolina Moreno Márquez
1 joint publications
Paula Fernández Álvarez
1 joint publications
Luisa Castro Laria
1 joint publications
Federico Argüelles Arias
1 joint publications
Ángel Caunedo Álvarez
1 joint publications
Blas José Gómez Rodríguez
1 joint publications
Pilar Navajas Hernández
1 joint publications
Jaime González-Antuña
